188 related articles for article (PubMed ID: 11791120)
1. International consensus meeting on the treatment of primary breast cancer 2001, St. Gallen, Switzerland.
Thuerlimann B
Breast Cancer; 2001; 8(4):294-7. PubMed ID: 11791120
[No Abstract] [Full Text] [Related]
2. [Surgical, radiation and drug treatment of breast cancer].
Pereslegin IA; Nikitina TP
Med Radiol (Mosk); 1990 Jun; 35(6):39-44. PubMed ID: 2192219
[No Abstract] [Full Text] [Related]
3. [Inflammatory breast cancer: clinical course, diagnosis and treatment].
Borisov VI; Chkhikvadze TV
Vopr Onkol; 2008; 54(1):86-9. PubMed ID: 18416065
[TBL] [Abstract][Full Text] [Related]
4. Optimal management of ductal carcinoma in situ of the breast.
Sakorafas GH; Farley DR
Surg Oncol; 2003 Dec; 12(4):221-40. PubMed ID: 14998563
[TBL] [Abstract][Full Text] [Related]
5. The impact of loco-regional radiotherapy on the survival of breast cancer patients. Arbiter.
Mauriac L
Eur J Cancer; 2000 Oct; 36(15):1905-8. PubMed ID: 11000568
[No Abstract] [Full Text] [Related]
6. The impact of loco-regional radiotherapy on the survival of breast cancer patients. Contra.
Delozier T
Eur J Cancer; 2000 Oct; 36(15):1902-5. PubMed ID: 11000567
[No Abstract] [Full Text] [Related]
7. [Randomized trial on the effect of radiotherapy in addition to 6 cycles CMF in node-positive breast cancer].
Noël G; Mazeron JJ
Cancer Radiother; 2001 Apr; 5(2):206-7. PubMed ID: 11355592
[No Abstract] [Full Text] [Related]
8. The impact of loco-regional radiotherapy on the survival of breast cancer patients. Pro.
Cutuli B
Eur J Cancer; 2000 Oct; 36(15):1895-902. PubMed ID: 11000566
[No Abstract] [Full Text] [Related]
9. Personalized adjuvant therapies: lessons from the past: the opening address by the St. Gallen 2013 award recipient.
Goldhirsch A
Breast; 2013 Aug; 22 Suppl 2():S3-7. PubMed ID: 24074788
[TBL] [Abstract][Full Text] [Related]
10. Definition and impact of pathologic complete response on prognosis after neoadjuvant chemotherapy in various intrinsic breast cancer subtypes.
von Minckwitz G; Untch M; Blohmer JU; Costa SD; Eidtmann H; Fasching PA; Gerber B; Eiermann W; Hilfrich J; Huober J; Jackisch C; Kaufmann M; Konecny GE; Denkert C; Nekljudova V; Mehta K; Loibl S
J Clin Oncol; 2012 May; 30(15):1796-804. PubMed ID: 22508812
[TBL] [Abstract][Full Text] [Related]
11. Adjuvant systemic therapy in breast cancer. Part 1: Adjuvant hormone therapy.
Boyages J; Tiver KW
Aust N Z J Surg; 1992 May; 62(5):354-63. PubMed ID: 1575655
[No Abstract] [Full Text] [Related]
12. [Treatment of breast cancer with ipsilateral supraclavicular node metastases].
Ning L; Yu J; Lin C
Zhonghua Zhong Liu Za Zhi; 1995 Mar; 17(2):139-41. PubMed ID: 7656807
[TBL] [Abstract][Full Text] [Related]
13. [Locoregional radiotherapy after mastectomy and chemotherapy for breast cancer: prolonged survival and better local tumor control].
Struikmans H; van Tienhoven G; Jobsen JJ; Jager JJ; Borger JH; Scheijmans LJ
Ned Tijdschr Geneeskd; 1999 Jan; 143(2):71-3. PubMed ID: 10086106
[TBL] [Abstract][Full Text] [Related]
14. Optimising radiation treatment decisions for patients who receive neoadjuvant chemotherapy and mastectomy.
Hoffman KE; Mittendorf EA; Buchholz TA
Lancet Oncol; 2012 Jun; 13(6):e270-6. PubMed ID: 22652235
[TBL] [Abstract][Full Text] [Related]
15. Ten-year outcome after combined modality therapy for inflammatory breast cancer.
Harris EE; Schultz D; Bertsch H; Fox K; Glick J; Solin LJ
Int J Radiat Oncol Biol Phys; 2003 Apr; 55(5):1200-8. PubMed ID: 12654428
[TBL] [Abstract][Full Text] [Related]
16. [Multi-modal treatment in breast cancer. The prognostic role and correlation between relapse and metastasis].
Munteanu A; Munteanu F; Bild E
Rev Med Chir Soc Med Nat Iasi; 2009; 113(3):941-6. PubMed ID: 20191859
[TBL] [Abstract][Full Text] [Related]
17. [-Adjuvant systemic therapy of breast carcinoma-].
Goldhirsch A; Castiglione-Gertsch M
Arch Gynecol Obstet; 1995; 256 Suppl():S93-103. PubMed ID: 8619668
[No Abstract] [Full Text] [Related]
18. Adjuvant therapy for breast cancer--results from the USA consensus conference.
Abrams JS
Breast Cancer; 2001; 8(4):298-304. PubMed ID: 11791121
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of stage I-IIA breast cancer of medial-central localization].
Datsenko VS
Khirurgiia (Mosk); 1998; (11):35-7. PubMed ID: 9864983
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of nodal involvement region in clinical stage IIIc breast cancer patients who received primary systemic treatment, surgery, and radiotherapy.
Noh JM; Kim KH; Park W; Suh CO; Huh SJ; Choi DH; Keum KC; Kim YB
Breast; 2015 Oct; 24(5):637-41. PubMed ID: 26283599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
